News

Dive into the latest news, press releases and reports from the Abacus Medicine Group.

Abacus Medicine Group: Record full-year result

The Abacus Medicine Group exceeded the guidance ranges for both revenue and profitability in 2023. A combination of high demand in core sales markets and solid commercial execution drove organic revenue growth of 18% to EUR 1,210 million and EBITDA growth of 82% to EUR 47.5 million.

Read more

For media enquiries,
please contact:

OLE LINDHARDT
Head of Communications